Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
HER2Gene Amplification in Breast Cancer
2012
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Ovarian cancer
2014 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Footprints of selection in the ancestral admixture of a New World Creole cattle breed
2011 Standout
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study
2011
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
2011
Non-coding RNAs in human disease
2011 Standout
The hallmarks of cancer
2012 Standout
Long noncoding RNAs and human disease
2011 Standout
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
2008
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Marine natural products
2015 Standout
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
2003
Long Noncoding RNAs: Past, Present, and Future
2013 Standout
Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report
2014
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
2010
Kinase Inhibitors of Marine Origin
2013
Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles
2015 StandoutNobel
Works of Lydia Usha being referenced
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer
2007
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies
2011
Mesenchymal Stem Cells Develop Tumor Tropism but Do Not Accelerate Breast Cancer Tumorigenesis in a Somatic Mouse Breast Cancer Model
2013
Identification of downstream targets of the putative tumor suppressor gene on 8p by differential gene expression analysis
2001